Skip to main content
. 2011 May 3;9(5):e1001054. doi: 10.1371/journal.pbio.1001054

Figure 3. fMRI data related to unfair proposals.

Figure 3

In the placebo group (n = 18), we replicated data from Sanfey et al. [7] in that unfair proposals elicited activity in (A) right ACC (Montreal Neurological Institute space coordinates (x, y, z): [9 48 24], Z = 3.15, p<0.001, uncorrected) and (B) bilateral dlPFC (Montreal Neurological Institute space coordinates (x, y, z): left, [−24 36 54], Z = 4.04, p<0.001, uncorrected; right, [30 36 51], Z = 4.04, p<0.001, uncorrected). There were more expressed responses in the placebo group (interaction placebo unfair−fair proposals>oxazepam unfair−fair proposals) with an increased activation in (C) left mPFC ([−6 66 18], Z = 3.77, p<0.05, cluster level corrected) and ACC ([9 48 24], Z = 3.57, p<0.05, cluster level corrected) and (D) bilateral amygdala (left, [−18 −6 −18], Z = 3.25, p<0.05, corrected; right, [18 0 −18], Z = 3.03, p<0.05, corrected). Treatment with oxazepam (n = 18) lowered the neural responses related to unfair proposals.